Literature DB >> 819460

Neutrophil function in gram-negative rod bacteremia. The interaction between phagocytic cells, infecting organisms, and humoral factors.

R J Weinstein, L S Young.   

Abstract

To assess the phagocytic and bactericidal function of neutrophils in the acute stages of gram-negative rod bacteremia, cells from 30 nonleukopenic patients were studied in a test system utilizing plasma obtained simultaneously with culture-positive blood, the autologous infecting strain, and two laboratory test strains of Staphylococcus aureus and Pseudomonas aeruginosa. Results were compared to those obtained with normal neutrophils and plasma. Patient and control plasma were simultaneously tested with each source of phagocytic cells to localize any abnormalities. Four patients had a defect against their infecting strain, 33% of the inoculum phagocytized and killed versus 80% by controls. In these cases differences were localized to the patients' plasma, as normal plasma tested with patients' cells reversed the defect. Thus, four patients had impaired opsonization when compared to normal controls, but we also observed that 11 of 30 bacteremic isolates, all Escherichia coli, showed absolute or relative resistance to phagocytosis in the patient and control assay system. No intrinsic granulocyte killing abnormalities were noted. There was poor correlation between results obtained with infecting strains compared to laboratory test organisms. We conclude that in patients without evidence of an inherited neutrophil bactericidal disorder, recurrent infection, or treatment with cytotoxic drugs, intrinsic bactericidal defects are uncommon at the onset of gram-negative bacteremia, and impaired opsonization is the most commonly encountered cause of neutrophil dysfunction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819460      PMCID: PMC333170          DOI: 10.1172/JCI108449

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  THE PHAGOCYTIC ACTIVITY OF POLYMORPHONUCLEAR LEUKOCYTES OBTAINED FROM PATIENTS WITH DIABETES MELLITUS.

Authors:  J D BYBEE; D E ROGERS
Journal:  J Lab Clin Med       Date:  1964-07

2.  STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM.

Authors:  J G HIRSCH; B STRAUSS
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

3.  A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes.

Authors:  B H LANDING; H S SHIRKEY
Journal:  Pediatrics       Date:  1957-09       Impact factor: 7.124

4.  Neutrophil granulocyte function in bacterial infections.

Authors:  C O Solberg; K B Hellum
Journal:  Lancet       Date:  1972-10-07       Impact factor: 79.321

5.  Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus.

Authors:  L Brandt; H Hedberg
Journal:  Scand J Haematol       Date:  1969

6.  Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer.

Authors:  R I Lehrer; M J Cline
Journal:  Cancer       Date:  1971-05       Impact factor: 6.860

7.  Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.

Authors:  R K Root; A S Rosenthal; D J Balestra
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

8.  Influence of the alternate complement pathway in opsonization of several bacterial species.

Authors:  A Forsgren; P G Quie
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

9.  Effect of osmolarity on phagocytosis.

Authors:  A J SBARRA; W SHIRLEY; J S BAUMSTARK
Journal:  J Bacteriol       Date:  1963-02       Impact factor: 3.490

10.  Studies on hemagglutination and hemolysis by escherichia coli antisera.

Authors:  E NETER; L F BERTRAM; D A ZAK; M R MURDOCK; C E ARBESMAN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

View more
  14 in total

Review 1.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

2.  [Measuring chemiluminescence in phagocytic granulocytes--simultaneously a parameter of their killing function?].

Authors:  L Dziwisch; B Kremer; J Heesemann; D Bornholdt; D Henne-Bruns
Journal:  Langenbecks Arch Chir       Date:  1987

3.  In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.

Authors:  P Stevens; D J Winston; K Van Dyke
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

4.  Correlation between the susceptibility of E. coli to phagocytosis and their ability to invade HeLa cells in vitro.

Authors:  F Cian; B Bisiacchi; G D Rottini; P Patriarea
Journal:  Experientia       Date:  1977-08-15

Review 5.  Immunological aspects to severe bacterial sepsis.

Authors:  N Clumeck; C George
Journal:  Intensive Care Med       Date:  1981-04       Impact factor: 17.440

Review 6.  Phagocytosis. Clinical disorders of recognition and ingestion.

Authors:  T P Stossel
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

7.  Phagocytic resistance of Escherichia coli K-1 isolates and relationship to virulence.

Authors:  R Weinstein; L S Young
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

8.  A sequential, prospective analysis of immunologic abnormalities and infection following severe thermal injury.

Authors:  J W Alexander; C K Ogle; J D Stinnett; B G Macmillan
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

9.  Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.

Authors:  P D Lew; R Zubler; P Vaudaux; J J Farquet; F A Waldvogel; P H Lambert
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

10.  Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections.

Authors:  D J Evans; D G Evans; C Höhne; M A Noble; E V Haldane; H Lior; L S Young
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.